| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |